Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues.

[1]  E. Chi,et al.  Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). , 1999, Journal of immunology.

[2]  C. Murry,et al.  Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. , 1999, Circulation.

[3]  C. Payá,et al.  Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. , 1999, Journal of immunology.

[4]  Ingo Schmitz,et al.  The Role of c-FLIP in Modulation of CD95-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[5]  K. Walsh,et al.  Oxidized LDL activates fas-mediated endothelial cell apoptosis. , 1998, The Journal of clinical investigation.

[6]  F. Marumo,et al.  Levels of soluble Fas ligand in myocarditis. , 1998, The American journal of cardiology.

[7]  D. Smith,et al.  Cardiomyocyte transplantation in a porcine myocardial infarction model. , 1998, Cell transplantation.

[8]  J. Tschopp,et al.  Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity , 1998, The Journal of experimental medicine.

[9]  S. Nagata,et al.  Downregulation of Fas ligand by shedding , 1998, Nature Medicine.

[10]  G. D. De Meyer,et al.  RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. , 1998, The American journal of pathology.

[11]  M. Hayden,et al.  Cell death attenuation by `Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex , 1998, Cell Death and Differentiation.

[12]  Jennifer L Hall,et al.  Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease , 1998, Nature Medicine.

[13]  K. Maehara,et al.  Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. , 1998, Circulation.

[14]  B. Trask,et al.  MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Libby,et al.  Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[16]  P. M. Davis,et al.  Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. , 1997, Journal of immunology.

[17]  Y. Goltsev,et al.  CASH, a Novel Caspase Homologue with Death Effector Domains* , 1997, The Journal of Biological Chemistry.

[18]  S. Srinivasula,et al.  FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[19]  Margot Thome,et al.  Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[20]  D. Goeddel,et al.  Casper is a FADD- and caspase-related inducer of apoptosis. , 1997, Immunity.

[21]  M. Takemura,et al.  Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. , 1997, Journal of the American College of Cardiology.

[22]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[23]  C. Thompson,et al.  Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  V. Dixit,et al.  A Novel Family of Viral Death Effector Domain-containing Molecules That Inhibit Both CD-95- and Tumor Necrosis Factor Receptor-1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[25]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[26]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[27]  A. Saraste,et al.  Apoptosis in human acute myocardial infarction. , 1997, Circulation.

[28]  S M Schwartz,et al.  Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. , 1996, The Journal of clinical investigation.

[29]  L. Kedes,et al.  Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? , 1996, Circulation.

[30]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[31]  S. Hsu,et al.  In situ apoptosis assay for the detection of early acute myocardial infarction. , 1996, The American journal of pathology.

[32]  A. Abbas,et al.  Die and Let Live: Eliminating Dangerous Lymphocytes , 1996, Cell.

[33]  S. Nagata,et al.  Fas-mediated apoptosis. , 1996, Advances in experimental medicine and biology.

[34]  K. Yoshino,et al.  Metalloproteinase-mediated Release of Human Fas Ligand , 1995 .

[35]  M. Leon,et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.

[36]  P. Krammer,et al.  Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteases , 1995, European journal of immunology.

[37]  S. Schwartz,et al.  Death by any other name. , 1995, The American journal of pathology.

[38]  M. Tewari,et al.  Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product (*) , 1995, The Journal of Biological Chemistry.

[39]  R. Kloner,et al.  Reperfusion injury induces apoptosis in rabbit cardiomyocytes. , 1994, The Journal of clinical investigation.

[40]  O. H. Bing.  Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. , 1994, Journal of molecular and cellular cardiology.

[41]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[42]  J. McMurray,et al.  Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. , 1991, British heart journal.

[43]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[44]  Kathleen M. Smith,et al.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.

[45]  D. Garcia-Dorado,et al.  Cardiovascular Research , 1966 .